证券记录 · 已归档季度
VRDN
Viridian Therapeutics, Inc. · Healthcare · Biotechnology
14被追踪持有人
-2Δ持有人
33.44M持有股份
$467.46M报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -12.5% ·
股份流向 +2.1% ·
净新建仓位 -14.3%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | -12 | 71.65M | $1.32B | +6 | −18 |
| Q1 2026 | 88 | +7 | 66.96M | $1.32B | +11 | −5 |
| Q4 2025 | 82 | +2 | 62.58M | $1.95B | +4 | −1 |
| Q3 2025 | 16 | -1 | 34.97M | $754.70M | — | −1 |
| Q2 2025 | 14 | -2 | 33.44M | $467.46M | — | −2 |
| Q1 2025 | 13 | +2 | 10.47M | $141.20M | +2 | — |
| Q4 2024 | 11 | -2 | 10.88M | $208.63M | — | −2 |
| Q3 2024 | 12 | +3 | 5.78M | $131.57M | +3 | — |
| Q2 2024 | 9 | — | 3.15M | $40.97M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 12.24M | — | $171.10M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 12.24M | — | $171.10M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 12.24M | — | $171.10M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 5.52M | — | $77.18M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (被动) | 4.51M | — | $63.03M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (被动) | 4.51M | — | $63.03M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (被动) | 4.51M | — | $63.03M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (被动) | 4.51M | — | $63.03M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (被动) | 4.51M | — | $63.03M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 2.90M | +71.5% | $40.48M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 2.90M | +71.5% | $40.48M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (被动) | 2.55M | -10.9% | $35.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Geode Capital Management ✦ (被动) | 1.74M | +1.2% | $24.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Geode Capital Management ✦ (被动) | 1.74M | +1.2% | $24.34M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Marshall Wace ✦ | 1.21M | +11.4% | $16.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | Adage Capital Partners ✦ | 1.11M | -0.5% | $15.50M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 649.54K | +633.6% | $9.08M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 649.54K | +633.6% | $9.08M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Fisher Asset Management ✦ | 509.96K | -5.0% | $7.13M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 270.54K | +8.6% | $3.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 270.54K | +8.6% | $3.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 270.54K | +8.6% | $3.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 270.54K | +8.6% | $3.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 270.54K | +8.6% | $3.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Point72 Asset Management ✦ | 104.04K | -49.2% | $1.45M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 38 | Two Sigma Investments ✦ | 69.98K | -68.5% | $978,278 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Millennium Management ✦ | 59.44K | -80.0% | $830,915 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Renaissance Technologies | $4.32M | 曾为 0.0% |
| D. E. Shaw & Co. | $1.10M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 225 持有人, 111.32M 股份, $2.12B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Tousignant Jennifer
Officer · 4.21K 股 · $103,194
Aug 19
Tousignant Jennifer
Officer · 10.00K 股 · $245,000
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 20
SC 13G — Point72 Asset Management, L.P.
Aug 14
SC 13G/A — Paradigm Biocapital Advisors LP
Aug 14
SC 13G/A — Kynam Capital Management, LP
Aug 14
SC 13G/A — Deep Track Capital, LP
Aug 14
SC 13G — PRICE T ROWE ASSOCIATES INC /MD/
Aug 07
SC 13G — STATE STREET CORP
Jun 26
SC 13G — Paradigm Biocapital Advisors LP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据